Abstract
Introduction
Pancreatic cancer is an aggressive malignancy with a poor prognosis. The overall 5-year survival rate of pancreatic cancer is less than 5%, and has not improved significantly for years. Further understanding of the molecular carcinogenesis of pancreatic cancer is critical for designing effective ways to treat this type of malignancy.
Methods
In this study, we examine expression of hedgehog signaling molecules in 54 surgically removed pancreatic cancer specimens as well as seven available pancreatic cancer cell lines.
Results
We find that expression of Ptch is associated with tumor size, tumor differentiation, lymph node metastasis, and clinical stages, whereas expression of Smo is associated with tumor differentiation and lymph node metastasis. Our studies from pancreatic cancer cell lines indicate that targeted inhibition of hedgehog signaling by Smo signaling inhibitor KAAD-cyclopamine causes hedgehog target gene expression (Gli1) suppression, induces P21 expression and G1 cell population, and reduced expression of Cyclin D1 and IGF2.
Conclusions
These results indicate that hedgehog signaling activation is a very common event in pancreatic cancer and that targeted inhibition of hedgehog signaling may be effective in treatment of pancreatic cancer.
Similar content being viewed by others
References
Nair PN, De Armond DT, Adamo ML, Strodel WE, Freeman JW (2001) Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2. Oncogene 20(57):8203–8214. doi:10.1038/sj.onc.1205044
Nüsslein-Volhard C, Wieschaus E (1980) Mutations affecting segment number and polarity in Drosophila. Nature 287(5785):795–801. doi:10.1038/287795a0
Beachy PA, Karhadkar SS, Berman DM (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature 432(7015):324–331. doi:10.1038/nature03100
Kalderon D (2000) Transducing the hedgehog signal. Cell 103(3):371–374. doi:10.1016/S0092-8674(00)00129-X
Kayed H, Kleeff J, Osman T, Keleg S, Büchler MW, Friess H (2006) Hedgehog signaling in the normal and diseased pancreas. Pancreas 32(2):119–129. doi:10.1097/01.mpa.0000202937.55460.0c
Incardona JP, Gaffield W, Kapur RP, Roelink H (1998) The teratogenic veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125:3553–3562
Ramalho-Santos M, Melton DA, McMahon AP (2000) Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 127:2763–2772
Ingham PW, McMahon AP (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15(23):3059–3087. doi:10.1101/gad.938601
Echelard Y, Epstein DJ, St.-Jacques B, Shen L, Mohler J, McMahon JA et al (1993) Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell 75(7):1417–1430. doi:10.1016/0092-8674(93)90627-3
Aubin J, Déry U, Lemieux M, Chailler P, Jeannotte L (2002) Stomach regional specification requires Hoxa5-driven mesenchymal–epithelial signaling. Development 129(17):4075–4087
Lau J, Kawahira H, Hebrok M (2006) Hedgehog signaling in pancreas development and disease. Cell Mol Life Sci 63(6):642–652. doi:10.1007/s00018-005-5357-z
Bitgood MJ, Shen L, McMahon AP (1996) Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr Biol 6(3):298–304. doi:10.1016/S0960-9822(02)00480-3
Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K et al (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature 425(6960):846–851. doi:10.1038/nature01972
Morton JP, Mongeau ME, Klimstra DS, Morris JP, Lee YC, Kawaguchi Y et al (2007) Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA 104(12):5103–5108. doi:10.1073/pnas.0701158104
Pasca di Magliano M, Sekine S, Ermilov A, Ferris J, Dlugosz AA, Hebrok M (2006) Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 20:3161–3173. doi:10.1101/gad.1470806
Lee CJ, Dosch J, Simeone DM (2008) Pancreatic Cancer Stem Cells. J Clin Oncol 26:2806–2812. doi:10.1200/JCO.2008.16.6702
Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY et al (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425(6960):851–856. doi:10.1038/nature02009
Shafaee Z, Schmidt H, Du W, Posner M, Weichselbaum R (2006) Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells. Cancer Chemother Pharmacol 58(6):765–770. doi:10.1007/s00280-006-0227-4
Liu MS, Yang PY, Yeh TS (2007) Sonic hedgehog signaling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma. Pancreas 34(3):340–346. doi:10.1097/mpa.0b013e3180333ab5
Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, Fernández-Zapico ME et al (2009) GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23(1):24–36. doi:10.1101/gad.1753809
Denef N, Neubüser D, Perez L, Cohen SM (2000) Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened. Cell 102(4):521–531. doi:10.1016/S0092-8674(00)00056-8
Kayed H, Kleeff J, Keleg S, Guo J, Ketterer K, Berberat PO et al (2004) Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer. Int J Cancer 110(5):668–676. doi:10.1002/ijc.20194
Kiselyov AS (2006) Targeting the hedgehog signaling pathway with small molecules. Anticancer Agents Med Chem 6(5):445–449. doi:10.2174/187152006778226495
Miller SJ, Yu TC (2002) Cyclopamine as a potential therapeutic agent for treatment of tumors related to hedgehog pathway mutations. Dermatol Surg 28(2):187. doi:10.1046/j.1524-4725.2002.01179.x
Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P et al (2006) Dysregulation of the hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 27(4):748–757. doi:10.1093/carcin/bgi292
Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L et al (2000) Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406(6799):1005–1009. doi:10.1038/35023008
Huang S, He J, Zhang X, Bian Y, Yang L, Xie G et al (2006) Activation of the hedgehog pathway in human hepatocellular carcinoma. Carcinogenesis 27(7):1334–1340. doi:10.1093/carcin/bgi378
Cohen MM Jr (2003) The hedgehog signaling network. Am J Med Genet A 123(1):5–28. doi:10.1002/ajmg.a.20495
Chen X, Horiuchi A, Kikuchi N, Osada R, Yoshida J, Shiozawa T et al (2007) Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: its inhibition leads to growth suppression and apoptosis. Cancer Sci 98(1):68–76. doi:10.1111/j.1349-7006.2006.00353.x
Grant sponsor
Grant sponsor is from National Natural Science Foundation (30772120 to YM Yang).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, Y., Tian, X., Xie, X. et al. Expression and regulation of hedgehog signaling pathway in pancreatic cancer. Langenbecks Arch Surg 395, 515–525 (2010). https://doi.org/10.1007/s00423-009-0493-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-009-0493-9